Volume 19, Number 4—April 2013
Human Enterovirus Genotype C104, China
To the Editor: Human enteroviruses (EVs) are small, nonenveloped RNA viruses belonging to the family Picornaviridae. Approximately 100 EV genotypes have been identified. Recently, EV68 epidemics in respiratory tract infections (RTIs) have been reported worldwide (1,2). Moreover, rarely detected EVs (e.g., EV-C104 and EV-C109) have been increasingly identified in patients with RTIs (3–7), indicating a possible association of EVs with respiratory syndromes.
Little is known about the role of EV-C104 in RTIs. EV-C104 has been reported in 3 countries: Switzerland (7 children with pneumonia or otitis media) (3), Italy (3 adults and 4 children with RTIs) (4,7), and Japan (1 adult with an upper RTI [URTI](5). We report additional EV-C104 strains in 4 children with lower RTIs and in 1 adult with a URTI in China.
To identify EV infections, we collected nasopharyngeal aspirates from 3,108 children (1,963 boys) ≤14 years of age (median age 12 months; age range 0.3–168 months) who had lower RTIs at admission to Beijing Children’s Hospital during March 2007–February 2012. Throat and nasal swab specimens were also collected from 9,232 adults (4,140 men) ≥ 15 years of age (median age 35.3 years; age range 15–97 years) with acute RTIs who received treatment at Peking Union Medical College Hospital during August 2006–February 2012. All samples were screened for influenza virus, parainfluenza virus type 1–4, respiratory syncytial virus (RSV), coronaviruses (229E, NL63, HKU1, and OC43), metapneumovirus, adenovirus, rhinovirus, bocavirus, and EVs (8). Overall, 37 (1.2%) children and 158 (1.7%) adults were positive for EV.
Because we could not amplify EV-C104 by using primers specific for the viral protein (VP) 1 region (9), we used a reverse transcription PCR to amplify the 5′-untranslated region/VP4/VP2 gene (10). Amplicons of ≈600 bp were obtained for samples from 5 patients: 4 boys 2–11 months of age (BCH2859A, BCH2892A, BCH2894A, and BCH3034A) and a 30-year-old man (PUMCH12286). BLAST analysis (www.ncbi.nlm.nih.gov) of sequences of these amplicons showed that the 590-nt sequences had 94.0% identity with that of the EV-C104 prototype strain CL-12310945 (EU840733). The amplicon contained 155 nt in the 5′-untranslated region, 207 nt in VP4, and 228 nt in VP2. Phylogenetic analysis of VP4/VP2 sequences showed that the 5 sequences obtained in this study (GenBank accession nos. JX560522–JX560526) belonged to genotype EV-C104 within the EV-C species (Figure).
Virus isolation for EV-C104 with Vero and H1-HeLa cells was unsuccessful. Although we screened 591, 797, 459, 664 and 597 samples from children for 5 consecutive years and 1,765, 1,978, 1,350, 1,562, 1,573, and 1,004 samples from adults for 6 consecutive years, we did not detect EV-C104 strains until November 2011–February 2012.
Nucleotide identity of the EV-C104 sequences from this study was 99.5%–100% among BCH strains and 97.7%–98.0% between the PUMCH strain and the BCH strains. Deduced amino acid sequences in VP4/VP2 among the BCH strains were identical, albeit for 1 aa difference for the PUMCH strain (BCH strains had Pro110, but the PUMCH strain had Leu110, which was consistent with strains detected in children and adults in Italy). Deduced amino acid sequences for all 5 strains isolated in this study had 97.9%–100.0% identity with those from Switzerland, Italy, and Japan. BCH strains were community acquired because these 4 patients came from different cities and were admitted to different wards on different dates.
The 4 EV-C104–positive boys all had fever and cough for >10 days before their hospitalization. Chest radiographs showed increased lung markings or patchy shadows diagnosed as pneumonia or bronchopneumonia. RSV or adenovirus was also detected in 3 of the boys. The fourth boy was positive for parainfluenza virus type 1, adenovirus, and bocavirus. Clinical outcomes for all 4 children were favorable. The EV-C104–positive man had fever, chills, pantalgia, and expectoration for 1 day before a URTI was diagnosed. EV-C104 was the only virus detected in this patient.
We compared relative viral loads for all viruses in the 5 patients and quantified viral load of EV-C104 and other viruses by using real-time PCR (methods available upon request). Median viral load in the 5 patients was 2.4 × 106 RNA copies/mL (range 5.6 × 104–7.0 × 106 copies RNA/mL (Table, Appendix).
Overall, we found few (5/12,340) EV-C104–positive specimens. All EV-C104–positive children were co-infected with RSV or adenoviruses (high viral loads) in our study. The role of EV-C104 in RTIs needs to be further studied. Nevertheless, the finding of EV-C104–positive adults with high viral loads in China (3.9 × 106 RNA copies/mL) and Italy (2.0 × 106 RNA copies/mL) (7) indicates a possible association between EV-C104 with RTIs. Our data also confirm a wide distribution of EV-C104.
This study was supported by the National Major Science and Technology Project for the Control and Prevention of Major Infectious Diseases in China (2012ZX10004-206), the National Science Foundation for Outstanding Young Scientists (81225014), and the Fondation Mérieux.
- Centers for Disease Control and Prevention. Clusters of acute respiratory illness associated with human enterovirus 68—Asia, Europe, and United States, 2008–2010. MMWR Morb Mortal Wkly Rep. 2011;60:1301–4 .
- Xiang Z, Gonzalez R, Wang Z, Ren L, Xiao Y, Li J, Coxsackievirus A21, enterovirus 68, and acute respiratory tract infection, China. Emerg Infect Dis. 2012;18:821–4.
- Tapparel C, Junier T, Gerlach D, Van-Belle S, Turin L, Cordey S, New respiratory enterovirus and recombinant rhinoviruses among circulating picornaviruses. Emerg Infect Dis. 2009;15:719–26.
- Piralla A, Rovida F, Baldanti F, Gerna G. Enterovirus genotype EV-104 in humans, Italy, 2008–2009. Emerg Infect Dis. 2010;16:1018–21.
- Kaida A, Kubo H, Sekiguchi J, Hase A, Iritani N. Enterovirus 104 infection in adult, Japan, 2011. Emerg Infect Dis. 2012;18:882–3.
- Yozwiak NL, Skewes-Cox P, Gordon A, Saborio S, Kuan G, Balmaseda A, Human enterovirus 109: a novel interspecies recombinant enterovirus isolated from a case of acute pediatric respiratory illness in Nicaragua. J Virol. 2010;84:9047–58 and.
- Piralla A, Lilleri D, Sarasini A, Marchi A, Zecca M, Stronati M, Human rhinovirus and human respiratory enterovirus (EV68 and EV104) infections in hospitalized patients in Italy, 2008–2009. Diagn Microbiol Infect Dis. 2012;73:162–7.
- Ren L, Gonzalez R, Wang Z, Xiang Z, Wang Y, Zhou H, Prevalence of human respiratory viruses in adults with acute respiratory tract infections in Beijing, 2005–2007. Clin Microbiol Infect. 2009;15:1146–53.
- Nix WA, Oberste MS, Pallansch MA. Sensitive, seminested PCR amplification of VP1 sequences for direct identification of all enterovirus serotypes from original clinical specimens. J Clin Microbiol. 2006;44:2698–704.
- Savolainen C, Blomqvist S, Mulders MN, Hovi T. Genetic clustering of all 102 human rhinovirus prototype strains: serotype 87 is close to human enterovirus 70. J Gen Virol. 2002;83:333–40 .
- Figure. . . Phylogenetic tree of human enteroviruses (EVs) for nucleotide sequences of the viral protein (VP) 4/VP2 gene region (435 nt, corresponding to nt positions 654–1,088 of EV-C104 prototype strain...
- Table. Viral load of EV C104 and other viruses in 5 patient samples, People’s Republic of China, March 2007–February 2012
Suggested citation for this article: Xiang Z, Xie Z, Wang Z, Ren L, Xiao Y, Li L, et al. Human enterovirus genotype C104, China [letter]. Emerg Infect Dis [Internet]. 2013 Apr [date cited]. http://dx.doi.org/10.3201/eid1904.121435
Please use the form below to submit correspondence to the authors or contact them at the following address:
Jianwei Wang, 9 Dong Dan San Tiao, Dongcheng District, Beijing 100730, People’s Republic of China
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: March 13, 2013
- Page last updated: March 13, 2013
- Page last reviewed: March 13, 2013
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)